Valproate Annual Risk Acknowledgement Form

If you use valproate while you are pregnant, there is a significant risk of serious harm to your child which may be identified at birth or early development. This form confirms that you or your caregiver/parent/responsible person understand the risks of using valproate (contained in...

This document has been prepared to serve as a guideline to healthcare professionals reporting adverse drug reactions, adverse event following immunisations and product quality problems. It represents South African Health Products Regulatory Authority’s (SAHPRA’s) current thinking on the safety, quality and efficacy of medicines....

This document has been prepared to serve as a recommendation to those who wish to import and export medicines in South Africa. The South African Health Products Regulatory Authority (SAHPRA) is committed to ensure that all medicines entering or leaving the country will retain the...

This guideline is intended to provide recommendations to applicants wishing to submit an application for a licence to manufacture, import or export a medicine or scheduled substances. It is not intended as an exclusive approach and should not be taken as a complete or authoritative...

The objective of this procedure is to define the process to be followed and to provide instruction to the Holder of the Certificate of Registration (HCR) when submitting an application for Post-Importation Testing Exemption or imported products. ...